Literature DB >> 17991499

Leptospirosis in the Andaman Islands, India.

P Vijayachari1, A P Sugunan, S Sharma, S Roy, K Natarajaseenivasan, S C Sehgal.   

Abstract

Leptospirosis is an emerging zoonosis. In the Andaman Islands during the early twentieth century, it occurred in the penal settlements of the British India Administration, mostly as Weil's disease, an acute febrile illness with hepato-renal complications. It was caused by leptospires belonging to groups Akiamy A and Andamans A. After the 1930s nothing further is known regarding the disease until the late 1980s, when Andaman haemorrhagic fever (AHF), a mysterious illness with the majority of cases presenting pulmonary involvement, appeared. AHF was later identified as leptospirosis and severe pulmonary haemorrhage was shown for the first time as a complication of leptospirosis from India. Leptospirosis continues to occur in the Islands annually. It generally presents as two separate clinical syndromes: the hepato-renal form, and the pulmonary form, which is associated with high case fatality rates ranging from 10 to 15%. Infections are due to a variety of serovars, Valbuzzi being the commonest. Leptospira interrogans sensu stricto has been the predominant infecting species. Doxycycline has been shown to confer a beneficial effect in reducing the clinical illness and mortality during outbreaks. The history of leptospirosis in the Islands, its epidemiology, clinical spectrum, characteristics of the isolates and control are reviewed and discussed in this article.

Entities:  

Mesh:

Year:  2007        PMID: 17991499     DOI: 10.1016/j.trstmh.2007.08.012

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  9 in total

1.  Leptospirosis as a cause of fever in urban Bangladesh.

Authors:  Emily A Kendall; Regina C LaRocque; Duy M Bui; Renee Galloway; Mary D Ari; Doli Goswami; Robert F Breiman; Stephen Luby; W Abdullah Brooks
Journal:  Am J Trop Med Hyg       Date:  2010-06       Impact factor: 2.345

2.  Transbronchial Invasion and Proliferation of Leptospira interrogans in Lung without Inflammatory Cell Infiltration in a Hamster Model.

Authors:  Yasuhiko Nikaido; Midori Ogawa; Kazumasa Fukuda; Mitsuru Yokoyama; Takaaki Kanemaru; Toshiyuki Nakayama; Mitsumasa Saito
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

Review 3.  New hypothesis for cause of epidemic among native Americans, New England, 1616-1619.

Authors:  John S Marr; John T Cathey
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

Review 4.  Malaria's indirect contribution to all-cause mortality in the Andaman Islands during the colonial era.

Authors:  G Dennis Shanks; Simon I Hay; David J Bradley
Journal:  Lancet Infect Dis       Date:  2008-07-01       Impact factor: 25.071

5.  Genetic affinities within a large global collection of pathogenic Leptospira: implications for strain identification and molecular epidemiology.

Authors:  Kishore Nalam; Ahmed Ahmed; Sundru Manjulata Devi; Paolo Francalacci; Mumtaz Baig; Leonardo A Sechi; Rudy A Hartskeerl; Niyaz Ahmed
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

6.  An unusual case of Weil's syndrome with paraparesis.

Authors:  Virendra C Patil; Harsha V Patil; Amit Sakaria; Satish Tryambake
Journal:  Indian J Crit Care Med       Date:  2011-04

7.  Leptospirosis in Hawaii, USA, 1999-2008.

Authors:  Alan R Katz; Arlene E Buchholz; Kialani Hinson; Sarah Y Park; Paul V Effler
Journal:  Emerg Infect Dis       Date:  2011-02       Impact factor: 6.883

Review 8.  The emergence of severe pulmonary hemorrhagic leptospirosis: questions to consider.

Authors:  Kim Nhang Truong; Jenifer Coburn
Journal:  Front Cell Infect Microbiol       Date:  2012-01-06       Impact factor: 5.293

Review 9.  Leptospirosis among the self-supporting convicts of Andaman Island during the 1920s--the first report on pulmonary haemorrhage in leptospirosis?

Authors:  P Vijayachari; A P Sugunan; S S Singh; P P Mathur
Journal:  Indian J Med Res       Date:  2015-07       Impact factor: 2.375

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.